Lanean...
Cytokine therapy restores antitumor responses of NK cells rendered anergic in MHC I-deficient tumors
Recent extraordinary advances in cancer immunotherapy rely primarily on marshaling T cell responses. Here we discuss how NK cell responses can be amplified. We find that MHC I-deficient tumors induce anergy of NK cells but that cytokine therapy restores NK cell activity and increases the survival of...
Gorde:
| Argitaratua izan da: | Oncoimmunology |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Taylor & Francis
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4760323/ https://ncbi.nlm.nih.gov/pubmed/26942049 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2014.1002725 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|